The Molecular Targets of Cannabinoids in the Treatment of Cancer and Inflammation
- 01Identifies CB1, CB2, vanilloid receptors, and GPR55 as primary molecular targets
- 02Notes potential for treating inflammation in neurodegenerative, gastrointestinal, and respiratory diseases
- 03Highlights anti-cancer properties including inhibition of cell migration and induction of apoptosis
- 04Underscores the endocannabinoid system's role in maintaining physiological homeostasis
Cannabinoids may modulate inflammation and cancer growth by interacting with specific receptors within the body's regulatory systems.
Objective: In this review, we discuss the emerging evidence for the effectiveness of cannabinoids in the treatment of cancer and inflammation. The remarkable effects of this study will help in supporting the traditional evidence for their successful application in the treatment of pain and cancer-related side effects.
Methods: We searched Pub Med (132 articles) and Google scholar (9 articles) databases and gathered the clinical (4 articles), and preclinical (28 articles) studies, reports on cell culture models (30 articles), and other original and review articles (78 articles) related to inflammation, cancer, and cannabinoids.
Results: Cannabinoids are described in three different forms, comprising endo- phyto- and synthetic compounds that exert biological effects. The molecular and cellular pathways of endogenous cannabinoids in the maintenance of homeostasis are well documented. In addition to classical cannabinoid receptors type 1 and 2, Vanilloid receptors and G protein-coupled receptor 55 were identified as common receptors. Subsequently, the effectiveness of phyto- and synthetic cannabinoids mediated by cannabinoid receptors has been demonstrated in the treatment of inflammatory diseases, including neurodegenerative diseases as well as gastrointestinal and respiratory inflammations. Another accepted property of cannabinoids is their anti-cancer effects. Cannabinoids were found to be effective in the treatment of lung, colorectal, prostate, breast, pancreas, and hepatic cancers. The anti-cancer effects of cannabinoids were characterized by their anti-proliferative property, inhibition of cancer cell migration, suppression of vascularization, and induction of apoptosis.
Conclusion: The current review provides an overview of the role of the endocannabinoid system in the mediation of physiological functions and the type and expression of cannabinoids receptors under physiological and pathological conditions. In addition, the molecular pathways involved in the effects of cannabinoids and the effectiveness of cannabinoids in the treatment of inflammations and cancers are highlighted.
- APA
- Alenabi Aylar, & Malekinejad Hassan (2021). The Molecular Targets of Cannabinoids in the Treatment of Cancer and Inflammation. https://fasciaresearchdatabase.com/the-molecular-targets-of-cannabinoids-in-the-treatment-of-cancer-and-inflammation/
- MLA
- Alenabi Aylar, and Malekinejad Hassan. "The Molecular Targets of Cannabinoids in the Treatment of Cancer and Inflammation." 2021, https://fasciaresearchdatabase.com/the-molecular-targets-of-cannabinoids-in-the-treatment-of-cancer-and-inflammation/.
- Chicago
- Alenabi Aylar, Malekinejad Hassan. 2021. "The Molecular Targets of Cannabinoids in the Treatment of Cancer and Inflammation.". https://fasciaresearchdatabase.com/the-molecular-targets-of-cannabinoids-in-the-treatment-of-cancer-and-inflammation/
- Ep. —Podcast Recommendations: One Idea Gives Birth to Another.
Människan & maskinen and Myter & mysterier Per Johansson and Eric Schüldt have together created several podcast series that explore human nature, technological development, and ex…
- Ep. —The Foundation of the Fascia Guide
Your guide to the guide All episodes are available on Spotify, iTunes and on the web here Fasciaguiden began in the spring of 2020 as a series of eight episodes. A conversation be…